3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Genitourinary
1
CNS
1
Conditions
Wilms Tumor
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Hodgkin Disease
1
Brain Neoplasms
1
Interventions
Temozolomide
2
Filgrastim
2
trametinib
1
sonidegib
1
sargramostim
1
ribociclib
1
entinostat
1
carboxyamido-triazole
1
Zoledronic Acid
1
Thalidomide
1
Psychiatric Rehabilitation
1
Paclitaxel
1
O(6)-benzylguanine
1
Granulocyte Colony-Stimulating Factor
1
Genistein
1
Gemcitabine
1
Fentanyl
1
Docetaxel
1
Carmustine
1
CLR1404
1
Bortezomib
1
90Y-octreotide, DOTA-Tyr(3)-
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive
×
Genistein
×
Lymphoid
×
Clear all
NCT02624388
2024-05-06
UVA-Gen001
University of Virginia
Phase 2
Terminated
4 enrolled
16 charts